Sandu Pharmaceuticals Ltd — Updates, 24-05-2025: Company Update

Sandu Pharmaceuticals has announced a board meeting on 28th May 2025 to consider the reclassification request from Akshath Finvest and Properties Private Limited. This entity, currently part of the promoter group holding 5.12% shares, seeks to be reclassified as a public shareholder. Akshath Finvest confirms it does not control or influence the company, has no management association, and meets all conditions for reclassification. Approval would alter shareholding structure and potentially impact public float, aligning with compliance and transparency goals important to shareholders.